Trials / Recruiting
RecruitingNCT06409910
Comparing Moderately Ultra Hypofractionated Radiation Treatments for Prostate Cancer
A Phase II Randomized Trial: ALTERNATE DAY ULTRAHYPOFRACTIONATED OR DAILY MODERATELY HYPOFRACTIONATED POST OPERATIVE RADIOTHERAPY
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 204 (estimated)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-institution, randomized, non-inferiority Phase II trial comparing external beam radiotherapy delivered as 54 Gy in 20 fractions to prostate bed +/- 44 Gy in 20 fractions to pelvic lymph nodes delivered daily with external beam radiotherapy delivered as 30 Gy in 5 fractions to prostate bed +/- 25 Gy in 5 fractions to pelvic lymph nodes delivered on alternate days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiotherapy | Non-institutional-standard radiotherapy |
Timeline
- Start date
- 2024-11-26
- Primary completion
- 2030-11-01
- Completion
- 2030-11-01
- First posted
- 2024-05-10
- Last updated
- 2026-03-23
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT06409910. Inclusion in this directory is not an endorsement.